All Posts

McFarland & Golde labs publish in June 5 2017 JAMA Neurol

Published: June 8th, 2017

Published: June 8th, 2017

Kelly DeMars – 2017 Bryan Robinson Grant

Published: June 8th, 2017

Nicola Rutherford

Former Graduate Student, Dr. Nicole Rutherford & labs publish in May 2017 Molecular Neurodegeneration

Published: May 31st, 2017

Dr. Yong Ran and the Golde Lab publish in May 2017 EMBO Molecular Medicine

Published: May 30th, 2017

Former Grad Student, Dr. Kim Hawkins & Candelario-Jalil lab publish in April 2017 Brain and Behavior

Published: May 22nd, 2017

BACKGROUND:

Resolution of inflammation is an emerging new strategy to reduce damage following ischemic stroke. Lipoxin A4 (LXA 4) is an anti-inflammatory, pro-resolution lipid mediator that reduces neuroinflammation in stroke. Since LXA 4 is rapidly inactivated, potent analogs have been synthesized, including BML-111. We hypothesized that post-ischemic, intravenous treatment with BML-111 for 1 week would provide neuroprotection and reduce neurobehavioral deficits at 4 weeks after ischemic stroke in rats. Additionally, we investigated the potential protective mechanisms of BML-111 on the post-stroke molecular and cellular profile.

Dr. Jacob Ayers & colleagues publish in April 2017 Biological Psychiatry

Published: May 18th, 2017

Dr. Leonid Moroz & colleagues publish in May 2017 Nature Communications

Published: May 18th, 2017

Dr. Tom Foster received a Distinguished Alumnus Award from Wake Forest University

Published: May 12th, 2017

Graduate Student, Kelly DeMars & Candelario-Jalil lab publish in April 2017 Journal of Experimental Neuroscience

Published: May 5th, 2017

DeMars KM, Yang C, Hawkins KE, McCrea AO, Siwarski DM, Candelario-Jalil E. Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats. J Exp Neurosci. […]